Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study

Last updated: March 25, 2025
Sponsor: University of Miami
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Obsessive-compulsive Disorder

Mood Disorders

Panic Disorders

Treatment

OCD-NET

Clinical Study ID

NCT06470893
20240483
  • Ages 18-90
  • All Genders

Study Summary

The overarching goal of this protocol is to investigate mechanisms that influence symptom outcomes of exposure and response prevention (ERP) therapy for OCD. Mechanisms may include affective processes, learning factors, cognitive factors, or other constructs that could influence treatment outcomes. The study team will conduct this research within the context of an effective online treatment for OCD called OCD-NET. OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • English-speaking

  • Located within the United States

  • 18-90 years old

  • Able to provide consent

  • Current diagnosis of OCD as assessed by clinical interview

Exclusion

Exclusion Criteria:

  • Adults unable to consent

  • Individuals who are not yet adults (infants, children, teenagers)

  • Participants currently located outside of the United States

  • Prisoners

  • Participants with hoarding as the primary OCD symptom

  • Severe mental illness (e.g. schizophrenia, substance abuse); organic brain syndrome;or serious, current suicidal/homicidal ideation (based on phone screening or initialassessment)

  • Concurrent enrollment in another psychotherapy treatment

  • Participants taking psychotropic medication may be excluded if:

  • They have started a brand new psychotropic medication within the last 12 weeks

  • They have changed the dose of their psychotropic medication within the last 4weeks

  • They anticipate that they cannot maintain the current dose of theirpsychotropic medication for the duration of the study

  • Participants may be excluded if they have any cognitive or physical impairments thatwould interfere with their participation (e.g., significant head injury, cognitivedisability, dementia).

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: OCD-NET
Phase:
Study Start date:
September 23, 2024
Estimated Completion Date:
September 01, 2025

Connect with a study center

  • University of Miami

    Miami, Florida 33146
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.